Management and a KOL discuss Gaucher Disease at a virtual event to be held on August 1 at 8:30 am. frln/register.aspx?conf=cc&page=frln&url=https://wsw.com/webcast/cc/frln/1378476′ target= ‘_blank’; rel=’nofollow’>Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FRLN:
- Freeline to hold a virtual event
- Freeline to Participate in Upcoming Investor Conferences
- Freeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201, in Gaucher Disease
- Freeline doses first patient in Phase 1/2 GALILEO-1 trial of FLT201
- Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s Disease